HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED EPITHELIAL OVARIAN-CANCER RESISTANT TO 1ST-LINE OR 2ND-LINE CHEMOTHERAPY

被引：36

作者：

MANGIONI, C

FRANCESCHI, S

LAVECCHIA, C

DINCALCI, M

机构：

[1] MARIO NEGRI INST PHARMACOL RES,I-20157 MILAN,ITALY

[2] UNIV MILAN,OSTETRICA & GINECOL CLIN 1,I-20133 MILAN,ITALY

来源：

关键词：

D O I：

10.1016/0090-8258(81)90131-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：314 / 318

页数：5

共 7 条

[1] TREATMENT OF ADVANCED CYSTADENOCARCINOMA OF THE OVARY WITH GESTRONOL AND CONTINUOUS ORAL CYCLOPHOSPHAMIDE
GUTHRIE, D
[J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1979, 86 (07): : 497 - 500
[2] HOLT JA, 1979, OBSTET GYNECOL, V53, P50
[3] PROGESTERONE IN THE TREATMENT OF ADVANCED MALIGNANT TUMOURS OF BREAST, OVARY AND UTERUS
JOLLES, B
[J]. BRITISH JOURNAL OF CANCER, 1962, 16 (02) : 209 - 221
[4] MALKASIAN GD, 1973, CANCER CHEMOTH REP 1, V57, P241
[5] MALKASIAN GD, 1977, CANCER TREAT REP, V61, P913
[6] VARGA A, 1964, OBSTET GYNECOL, V23, P51
[7] WARD HWC, 1972, J OBSTET GYN BR COMM, V79, P555